ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

ClinicalTrials.gov ID: NCT06637514

Public ClinicalTrials.gov record NCT06637514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 26, 2026, 1:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06637514
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

  • JNT-517 Tablet Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2025
Primary completion
May 8, 2026
Completion
May 8, 2026
Last update posted
Apr 23, 2026

2025 – 2026

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
University of Florida (UF) Health Shands Hospital Gainesville Florida 32608 Recruiting
University of South Florida Tampa Florida 33606 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Children's Medical Center Dallas Dallas Texas 75235 Recruiting
University of Texas Health (UTHealth) Science Center at Houston Houston Texas 77030 Recruiting
Utah Health - The University of Utah Hospital Salt Lake City Utah 84112 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06637514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced Apr 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06637514 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →